Single User License
INR 96975
Site License
INR 193950
Corporate User License
INR 290925

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Panacea Pharmaceuticals, Inc.-Product Pipeline Review-2015

Panacea Pharmaceuticals, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07158CDB
  • |
  • Pages: 23
  • |
  • June 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Panacea Pharmaceuticals, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Panacea Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Panacea Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Panacea Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Panacea Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Panacea Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Panacea Pharmaceuticals, Inc.'s pipeline products

Reasons To Buy

Evaluate Panacea Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Panacea Pharmaceuticals, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Panacea Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Panacea Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Panacea Pharmaceuticals, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Panacea Pharmaceuticals, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Panacea Pharmaceuticals, Inc. Snapshot 5

Panacea Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Panacea Pharmaceuticals, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Panacea Pharmaceuticals, Inc.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Panacea Pharmaceuticals, Inc.-Pipeline Products Glance 10

Panacea Pharmaceuticals, Inc.-Early Stage Pipeline Products 10

Preclinical Products/Combination Treatment Modalities 10

Discovery Products/Combination Treatment Modalities 11

Panacea Pharmaceuticals, Inc.-Drug Profiles 12

PAN-22 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

PAN-622 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

PAN-811 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Vaccine to Target HAAH for Oncology 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Panacea Pharmaceuticals, Inc.-Pipeline Analysis 17

Panacea Pharmaceuticals, Inc.-Pipeline Products by Target 17

Panacea Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 18

Panacea Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 19

Panacea Pharmaceuticals, Inc.-Dormant Projects 20

Panacea Pharmaceuticals, Inc.-Locations And Subsidiaries 21

Head Office 21

Appendix 22

Methodology 22

Coverage 22

Secondary Research 22

Primary Research 22

Expert Panel Validation 22

Contact Us 22

Disclaimer 23

List of Tables

Panacea Pharmaceuticals, Inc., Key Information 5

Panacea Pharmaceuticals, Inc., Key Facts 5

Panacea Pharmaceuticals, Inc.-Pipeline by Indication, 2015 7

Panacea Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 8

Panacea Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 9

Panacea Pharmaceuticals, Inc.-Preclinical, 2015 10

Panacea Pharmaceuticals, Inc.-Discovery, 2015 11

Panacea Pharmaceuticals, Inc.-Pipeline by Target, 2015 17

Panacea Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 18

Panacea Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 19

Panacea Pharmaceuticals, Inc.-Dormant Developmental Projects,2015 20

List of Figures

Panacea Pharmaceuticals, Inc.-Pipeline by Top 10 Indication, 2015 7

Panacea Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 8

Panacea Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 9

Panacea Pharmaceuticals, Inc.-Pipeline by Top 10 Target, 2015 17

Panacea Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 18

Panacea Pharmaceuticals, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of Panacea Pharmaceuticals, Inc.; Panacea Pharmaceuticals, Inc. - Key Therapeutics; Panacea Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Panacea Pharmaceuticals, Inc. - News; Panacea Pharmaceuticals, Inc. - Latest Updates; Panacea Pharmaceuticals, Inc. - Pipeline; Panacea Pharmaceuticals, Inc. - Discontinued/Dormant Projects

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]